The kidney evaluation and awareness program in sheffield (KEAPS): A community-based screening for microalbuminuria in a british population

Nephron - Clinical Practice

Volumn 116, Issue 2, 2010, Pages

  Bello, Aminu K ^a   Peters, Jean ^b   Wight, Jeremy ^c   El Nahas, Meguid ^a  

^a Sheffield Kidney Institute   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c SHEFFIELD CITY COUNCIL   (United Kingdom)

Author keywords

Albuminuria; Cardiovascular disease; Chronic kidney disease; Early detection; Prevention

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MICROALBUMINURIA; NEPHELOMETRY; OBESITY; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCREENING; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; AWARENESS; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; ENGLAND; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; PILOT PROJECTS; POPULATION SURVEILLANCE; PROGRAM EVALUATION; RESIDENCE CHARACTERISTICS; RISK FACTORS; YOUNG ADULT;

EID: 77952493171     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314658     Document Type: Article

References (34)

1. Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, de Jong PE: An ele-vated urinary albumin excretion predicts de novo development of renal function impair-ment in the general population. Kidney Int Suppl 2004; 92:S18-S21.
2. Bakris GL: Microalbuminuria: what is it? Why is it important? What should be done about it? J Clin Hypertens 2001; 3: 99-102.
3. de Zeeuw D: Albuminuria, not only a cardio-vascular/renal risk marker, but also a target for treatment? Kidney Int 2004;(Suppl 92):S2-S6.
4. Levey AS, Coresh J, Balk E, et al: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classifi-cation, and stratification. Ann Intern Med 2003; 139: 137-147.
5. Jones CA, Francis ME, Eberhardt MS, Chav-ers B, Coresh J, Engelgau M, Kusek JW, Byrd-Holt D, Narayan KM, Herman WH, Jones CP, Salive M, Agodoa LY: Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39:445-459. (Pubitemid 34194620)
6. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, Van Gilst WH, De Zeeuw D, De Jong PE, Prevend Study Group. Microalbuminuria is common, also in a nondiabetic, nonhypertensive popula-tion, and an independent indicator of cardio-vascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249: 519-526.
7. Chadban SJ, Briganti EM, Kerr PG, et al: Prevalence of Kidney Damage in Australian Adults: the AusDiab Kidney Study. J Am Soc Nephrol 2003; 14:S131-S138.
8. Yudkin JS, Forrest RD, Jackson CA: Micro-albuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988; 2: 530-533.
9. Winocour PH, Harland JO, Millar JP, Laker MF, Alberti KG: Microalbuminuria and as-sociated cardiovascular risk factors in the community. Atherosclerosis 1992; 93: 71-81.
10. Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP: Microalbuminuria: associations with height and sex in non-dia-betic subjects. BMJ 1993; 306: 240-242.
11. Yuyun MF, Khaw KT, Luben R, et al: Micro-albuminuria independently predicts all-cause and cardiovascular mortality in a Brit-ish population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 2004; 33: 189-198.
12. Day N, Oakes S, Luben R, Khaw KT, Bing-ham S, Welch A, Wareham N: EPIC-Norfolk: study design and characteristics of the co-hort. European Prospective Investigation of Cancer. Br J Cancer 1999; 80(Suppl 1):95-103.
13. UK Government Actuary Department: http://www.gad.gov.uk/ Demography%5FData/Life-Tables/ (accessed July 28, 2007).
14. United Kingdom Census 2001 Sheffield (Local Authority): www.neighbourhood. statistics.gov.uk (accessed July 11, 2005).
15. UK CKD guidelines for identification, man-agement and referral of adults: www.renal. org/CKDguide (accessed December, 2007).
16. Levey AS, Atkins R, Coresh J, Cohen EP, Col-lins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improv-ing Global Outcomes. Kidney Int 2007; 72: 247-259.
17. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease, Evaluation Classification and Stratification. Kidney Disease Outcome Quality Initiative. Am J Kid Dis 2002; 39(Suppl 2) S1-S246.
18. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney dis-ease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12.
19. Romundstad S, Holmen J, Kvenild K, et al: Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøn-delag Health Study (HUNT), Norway. Am J Kidney Dis 2003; 42:466-473.
20. Yuyun MF, Khaw KT, Luben R, et al: Micro-albuminuria, cardiovascular risk factors and cardiovascular morbidity in a British popu-lation: the EPIC-Norfolk population-based study. Eur J Cardiovasc Prev Rehabil 2004; 11:207-213.
21. Gansevoort RT, Verhave JC, Hillege HL, et al: The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general popu-lation. Kidney Int Suppl 2005:S28-S35.
22. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De San-to NG: Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smok-ing: the Gubbio Population Study. Arch In-tern Med 1998; 158:1933-1939.
23. Kramer H, Luke A, Bidani A, et al: Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am J Kidney Dis 2005; 46: 587-594.
24. Fox CS, Larson MG, Leip EP, et al: Predictors of new-onset kidney disease in a communi-ty-based population. JAMA 2004; 291:844-850.
25. Valensi P, Assayag M, Busby M, et al: Micro-albuminuria in obese patients with or with-out hypertension. Int J Obes Relat Metab Disord 1996; 20: 574-579.
26. Bonnet F, Marre M, Halimi JM, et al: Waist circumference and the metabolic syndrome predict the development of elevated albu-minuria in non-diabetic subjects: the DESIR Study. J Hypertens 2006; 24:1157-1163.
27. Bello AK, De Zeeuw D, El Nahas AM, et al: Impact of weight change on albuminuria in the general population. Nephrol Dial Trans-plant 2007; 22:1619-1627.
28. Wang TJ, Evans JC, Meigs JB, et al: Low-grade albuminuria and the risks of hyperten-sion and blood pressure progression. Circu-lation 2005; 111: 1370-1376.
29. Rossi R, Chiurlia E, Nuzzo A, Cioni E, Ori-gliani G, Modena MG: Flow-mediated vaso-dilation and the risk of developing hyperten-sion in healthy postmenopausal women. J Am Coll Cardiol 2004; 44: 1636-1640.
30. Martins D, Tareen N, Zadshir A, et al: The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2006; 47: 965-971.
31. Jinks C, Ong BN, Croft P: Postal surveys in primary care: the hidden burden. Health Ex-pect 2001; 4:253-259.
32. Bolton-Smith C, Woodward M, Tunstall-Pe-doe H, Morrison C: Accuracy of the estimat-ed prevalence of obesity from self reported height and weight in an adult Scottish popu-lation. J Epidemiol Community Health 2000; 54:143-148.
33. Niedhammer I, Bugel I, Bonenfant S, Gold-berg M, Leclerc A: Validity of self-reported weight and height in the French GAZEL co-hort. Int J Obes Relat Metab Disord 2000; 24: 1111-1118.
34. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ: Agreement between self-report questionnaires and medical record data was substantial for diabetes, hyperten-sion, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004; 57: 1096-1103.